Actively Recruiting

Age: 60Years - 90Years
All Genders
Healthy Volunteers
NCT06584357

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Led by GAP Innovations, PBC · Updated on 2026-04-15

1200

Participants Needed

26

Research Sites

196 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Bio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine the primary objective. Digital biomarkers and blood-based biomarkers will be tested to determine whether a meaningful relationship exists between biomarkers alone or in combination with tau or amyloid brain pathology identified through PET images.

CONDITIONS

Official Title

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who Can Participate

Age: 60Years - 90Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must be between 60 to 90 years old at consent
  • Participants must have a study partner with at least 8 hours of weekly contact able to report on cognitive and functional abilities
  • Written consent must be provided by participant or legally authorized representative
  • Willingness to undergo MRI brain scan within 90 days and amyloid and tau PET scans within 120 days of consent
  • Willingness to comply with study procedures including blood sampling, genetic testing, and biospecimen storage
  • Fluency in the language used at the study site
  • Willingness to be contacted for future clinical research participation
  • Mini-Mental State Exam score between 16 and 30 inclusive at screening
Not Eligible

You will not qualify if you...

  • Unable to undergo amyloid and tau PET scans due to pregnancy, ligand sensitivity, poor venous access, contraindications, or excessive radiation exposure
  • Known negative amyloid PET scan in past 6 months
  • Contraindications to brain MRI
  • History of stroke or seizures within 1 year before screening
  • History of cancer within past 5 years except non-melanoma skin cancer or prostate cancer in situ
  • Known or suspected alcohol or drug abuse within 1 year before screening
  • Current unstable psychiatric symptoms interfering with study
  • Use of disease-modifying Alzheimer's treatments within 6 months prior to screening
  • Known HIV positive status unless controlled by medication
  • Serious or unstable medical conditions preventing study completion
  • Untreated vitamin B12 or folate deficiency or bladder infections that may affect cognition
  • Cognitive testing within 1 month before screening that could cause practice effect
  • Neurological disorders other than Alzheimer's that affect cognition
  • Geriatric Depression Scale score 8 or higher with clinical depression
  • Rey Auditory Verbal Learning Test t-score 1.2 standard deviations above mean
  • Weigh less than 110 pounds
  • Direct employee or family member of study site investigators or sponsor
  • Inability to complete cognitive tests due to poor vision or hearing
  • Known allergy or contraindication to pupil dilation drops for retinal scan
  • Enrollment in Alzheimer's clinical trials with disease-modifying treatments
  • Intention to use Alzheimer's medications outside approved clinical studies
  • Serious or unstable medical conditions precluding interventional research participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 26 locations

1

JEM Research Institute

Atlantis, Florida, United States, 33462

Actively Recruiting

2

Visionary Investigators Network

Aventura, Florida, United States, 33180

Actively Recruiting

3

K2 - Winter Garden

Clermont, Florida, United States, 34711

Actively Recruiting

4

Brain Matters Research

Delray Beach, Florida, United States, 33445

Actively Recruiting

5

Neuropsychiatric Research Center of SW Florida

Fort Myers, Florida, United States, 33912

Actively Recruiting

6

K2 Medical Research

Maitland, Florida, United States, 32751

Actively Recruiting

7

Clincloud

Melbourne, Florida, United States, 32940

Actively Recruiting

8

Visionary Investigators Network

Miami, Florida, United States, 33133

Actively Recruiting

9

Charter Research

Orlando, Florida, United States, 32803

Actively Recruiting

10

Progressive Medical Research

Port Orange, Florida, United States, 32127

Actively Recruiting

11

Intercoastal Medical Group, Inc.

Sarasota, Florida, United States, 34239

Actively Recruiting

12

Axiom Brain Health

Tampa, Florida, United States, 33609

Actively Recruiting

13

Conquest Research

Winter Park, Florida, United States, 32789

Actively Recruiting

14

Flourish Research - Chicago

Chicago, Illinois, United States, 60640

Actively Recruiting

15

Quest Research Institute

Farmington Hills, Michigan, United States, 48334

Actively Recruiting

16

Clinical Neurology Specialists

Las Vegas, Nevada, United States, 89147

Actively Recruiting

17

ADRC of Albany

Albany, New York, United States, 12208

Completed

18

Neuro-Behavioral Clinical Research Inc.

North Canton, Ohio, United States, 44720

Completed

19

Flourish Research - Philadelphia

Philadelphia, Pennsylvania, United States, 19462

Active, Not Recruiting

20

K2 Medical Research

East Providence, Rhode Island, United States, 02914

Actively Recruiting

21

Gadolin Research LLC

Beaumont, Texas, United States, 77702

Actively Recruiting

22

Re:Cognition Health

Houston, Texas, United States, 77030

Actively Recruiting

23

Toronto Memory Program

Toronto, Ontario, Canada, M3B 2S7

Actively Recruiting

24

NeuroClin Glasgow

Motherwell, North Lanarkshire, United Kingdom, ML1 4UF

Actively Recruiting

25

Re:Cognition Health

London, United Kingdom, W1G 8TA

Actively Recruiting

26

Dementia Research Centre, UCLH

London, United Kingdom, WC1N 3BG

Actively Recruiting

Loading map...

Research Team

A

Amanda Ng, MA

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia | DecenTrialz